Clinical Trial Update: Measuring the Effects of Continuous Dopaminergic Stimulation on Nocturnal Movements in Parkinson's Disease

View source ↗

Summary

A clinical trial evaluating continuous dopaminergic stimulation with Rotigotine for nocturnal movements in Parkinson's disease was terminated; no results are pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturnal Hypokinesia
• Parkinson Disease

Drugs mentioned

• Rotigotine (Neupro) (rotigotine)

Snippet

Sponsor: Sleep Medicine Centre Kempenhaeghe | Conditions: Nocturnal Hypokinesia, Parkinsons's Disease | Status: TERMINATED